Bill and Melinda Gates Foundation home page
1999 Annual Report Home
Letter from FoundersFoundation Overview1999 Grants
Grant InquiriesLeadership
Financial Reports
1999 Grants

 Vaccine Preventable Diseases

Reproductive and Child Health

Conditions Associated with Poverty

Libraries and Public Access to Information

Education

Pacific Northwest

Special Projects

Global Health - Vaccine Preventable Diseases

The foundation awarded 70 grants totaling $1,219,857,173 to improve health in the developing world. Of that amount, 9 grants, totaling $948,250,000, were designated for Vaccine Preventable Diseases.

12/7/99
Global Fund for Vaccines and Immunization

Global Fund for Vaccines and Immunization
Seattle, WA
$750,000,000 (over 5 years)

A grant to establish the Global Fund for Children's Vaccines, an independent, charitable organization which will manage financial contributions from a variety of donors. The Fund will immunize approximately 42 million children in 68 countries through the purchase of new vaccines for countries that meet rigorous qualification criteria.

11/22/99
China Foundation, Inc.

China Basic Health Services Project
Washington, DC
$2,000,000 (over 2 years)

A two-year contribution to the matching funds needed for specific activities on the China Basic Health Services Project, which is supported by the World Bank. The funds will be used for maternal/child health and immunization services.

11/22/99
United Nations Foundation

Strengthening Surveillance and Control of Vaccine-Preventable and Epidemic Prone Diseases
Washington, DC
$1,250,000 (over 3 years)

A three-year grant to the United Nations Foundation for the World Health Organization to implement surveillance and response activities at national and epidemiological block levels.

photo of smiling Indian girl11/22/99
International Vaccine Institute

Vaccines to Prevent Diseases of the Most Impoverished
Korea
$40,000,000 (over 5 years)

A five-year grant to develop, evaluate, and introduce vaccines against diseases of the most impoverished (The DOMI Program). The Program will be conducted in Bangladesh, China, India, Indonesia, Thailand, and Vietnam -- countries whose populations total about 2.7 billion people or more than 40% of the world's population.

11/22/99
Seattle Biomedical Research Institute

Malaria Vaccine Antigens
Seattle, WA
$5,000,000 (over 3 years)

A three-year grant to identify and validate new antigens that are necessary for an effective malaria vaccine. The project will systematically analyze all genes in the malaria genome using high throughput genomic technologies to identify new vaccine candidates.

8/4/99
Sequella Global Tuberculosis Foundation

Tuberculosis International Vaccine Collaboration
Rockville, MD
$25,000,000 (over 5 years)

For the creation of an international program to coordinate and facilitate the development of one or more vaccines that will: increase the efficacy of the current BCG vaccine for children; influence the dynamics of latent disease and prevent progression of latent TB to active infection; and prevent primary infection with M. tuberculosis as a prophylactic intervention.

5/13/99
United Nations Foundation

Polio Eradication in the Indian Sub-continent and Sub-Saharan Africa
Washington, DC
$50,000,000 (over 7 years)

The drive to eradicate polio from the world is the largest health initiative ever undertaken. Polio is easily prevented by immunization. The basic strategies to eradicate polio worldwide are focused on vaccinating every child in every nation. Efforts will focus on 13 of the 50 countries in which polio remains endemic. Funds from the Bill & Melinda Gates Foundation, along with commitments from other foundations, individuals and organizations, will be used by the World Health Organization to eradicate polio during the timeframe of this grant.

4/1/99
Program for Appropriate Technology in Health (PATH)

Malaria Vaccine Initiative (MVI)
Seattle, WA
$50,000,000 (over 10 years)

The Malaria Vaccine Initiative (MVI) will be created to advance development of promising malaria vaccine candidates. The MVI will operate as part of the Bill and Melinda Gates Children's Vaccine Program (CVP) and will be managed by PATH.

3/22/99
International AIDS Vaccine Initiative (IAVI)

Development on an HIV/AIDS Vaccine (II)
New York, NY
$25,000,000 (over 5 years)

IAVI plans to accelerate the development of globally effective AIDS vaccines. Applied research projects will fill critical gaps in knowledge related to AIDS vaccine development. These will be undertaken through contracts to research laboratories and will fall into three categories: vaccine design studies; clinical infrastructure studies; and non-human primate studies.

View Press Release

Photographer: Trevor Neilson

Download the 1998 Annual Report      Download the1999 Annual Report